Clarity Pharmaceuticals Ltd (CU6 AU)

Analysis

Health Care • Australia

Clarity Pharmaceuticals Limited operates as a radio-pharmaceutical company. The Company focuses on the developing targeted therapies for the treatment of cancer and other serious diseases. Clarity Pharmaceuticals serves customers worldwide.

Refresh

Exchange Announcement • 13 Oct 2026 06:30

SAR-bisPSMA Presentation - Drug & Device Conference

Exchange Announcement • 08 Oct 2026 07:00

SECuRE update

Exchange Announcement • 05 Oct 2026 15:43

Becoming a substantial holder

Exchange Announcement • 30 Sep 2026 14:00

CORPORATE GOVERNANCE STATEMENT

Exchange Announcement • 30 Sep 2026 13:52

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

SAR-bisPSMA Presentation - Drug & Device Conference

SECuRE update

Becoming a substantial holder

CORPORATE GOVERNANCE STATEMENT

Appendix 4G